Mechanisms of Anti-tumor Action of Corynebacterium Parvum. I. Potentiated Tumor-specific Immunity and Its Therapeutic Limitations

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1981 Sep 1

PMID 6974214

Citations 25

Authors

E S Dye

R J NORTH

C D Mills

Affiliations

Soon will be listed here.

Abstract

The anti-tumor mechanism in mice induced by a subcutaneous injection of syngeneic tumor cells admixed with Corynebacterium parvum was investigated. When mice were implanted in a hind footpad with x 2 1096) tumor cells admixed with 100 microgram C. parvum, the tumor that emerged grew progressively for about 9 d and then underwent progressive and complete regression. It was found that this C. parvum-induced regression was associated with the acquisition of a systemic, T cell-mediated mechanism of immunity to tumor-specific transplantation antigens, which enabled the host to cause the regression of an untreated test tumor growing simultaneously at a distant site. The generation of a C. parvum-potentiated anti-tumor response was dependent on the presence of tumor cells in close association with C. parvum, tumor immunogenicity, and the quantity of tumor antigen in the admixture. The anti-tumor immunity was specific for the tumor in the therapeutic admixture and could be adoptively transferred to normal recipients with Thy-1.2-positive lymphocytes, but not with serum. Complete regression of a distant test tumor by the C. parvum-tumor admixture was limited to tumors below a certain critical size.

Citing Articles

Adoptive T Cell Therapy Targeting MAGE-A4.

Chandora K, Chandora A, Saeed A, Cavalcante L Cancers (Basel). 2025; 17(3).

PMID: 39941782 PMC: 11815873. DOI: 10.3390/cancers17030413.

Tumor Profiling at the Service of Cancer Therapy.

Fernandez-Rozadilla C, Simoes A, LLeonart M, Carnero A, Carracedo A Front Oncol. 2021; 10:595613.

PMID: 33505911 PMC: 7832432. DOI: 10.3389/fonc.2020.595613.

Propionibacterium acnes Augments Antitumor, Anti-Angiogenesis and Immunomodulatory Effects of Melatonin on Breast Cancer Implanted in Mice.

Talib W, Saleh S PLoS One. 2015; 10(4):e0124384.

PMID: 25919398 PMC: 4412818. DOI: 10.1371/journal.pone.0124384.

Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells.

Liu K, Idoyaga J, Charalambous A, Fujii S, Bonito A, Mordoh J J Exp Med. 2005; 202(11):1507-16.

PMID: 16330814 PMC: 2213343. DOI: 10.1084/jem.20050956.

The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein.

Matsutake T, Srivastava P Proc Natl Acad Sci U S A. 2001; 98(7):3992-7.

PMID: 11274422 PMC: 31167. DOI: 10.1073/pnas.071523398.

References

Milas L, Scott M . Antitumor activity of Corynebacterium parvum. Adv Cancer Res. 1978; 26:257-306. DOI: 10.1016/s0065-230x(08)60090-1. View

Conley F, Remington J . Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice. J Natl Cancer Inst. 1978; 61(3):827-32. View

Bomford R . An analysis of the factors allowing promotion (rather than inhibition) of tumour growth by Corynebacterium parvum. Int J Cancer. 1977; 19(5):673-9. DOI: 10.1002/ijc.2910190512. View

Parr I . Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour. Br J Cancer. 1972; 26(3):174-82. PMC: 2008478. DOI: 10.1038/bjc.1972.24. View

Baldwin R . Immunological adjuvants in cancer immunotherapy. Dev Biol Stand. 1977; 38:3-12. View

Bast R, Bast B . Critical review of previously reported animal studies of tumor immunotherapy with nonspecific immunostimulants. Ann N Y Acad Sci. 1976; 277(00):60-93. DOI: 10.1111/j.1749-6632.1976.tb41692.x. View

TUTTLE R, NORTH R . Mechanisms of antitumor action of Corynebacterium parvum: the generation of cell-mediated tumor specific immunity. J Reticuloendothel Soc. 1976; 20(3):197-208. View

Mills C, NORTH R, Dye E . Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression. J Exp Med. 1981; 154(3):621-30. PMC: 2186449. DOI: 10.1084/jem.154.3.621. View

Berendt M, NORTH R, Kirstein D . The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity. J Exp Med. 1978; 148(6):1550-9. PMC: 2185110. DOI: 10.1084/jem.148.6.1550. View

10.

TUTTLE R, NORTH R . Mechanisms of antitumor action of Corynebacterium parvum: replicating short-lived T cells as the mediators of potentiated tumor-specific immunity. J Reticuloendothel Soc. 1976; 20(3):209-16. View

11.

Ojo E . Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria. Cell Immunol. 1979; 45(1):182-7. DOI: 10.1016/0008-8749(79)90374-5. View

12.

Murahata R, Zighelboim J . Inhibition of memory cell-mediated cytotoxic response by systemic administration of Corynebacterium parvum. Cell Immunol. 1979; 42(2):289-97. DOI: 10.1016/0008-8749(79)90194-1. View

13.

Woodruff M, Warner N . Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice. J Natl Cancer Inst. 1977; 58(1):111-6. DOI: 10.1093/jnci/58.1.11. View

14.

Woodruff M, BOAK J . Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer. 1966; 20(2):345-55. PMC: 2008959. DOI: 10.1038/bjc.1966.42. View

15.

Olivotto M, Bomford R . In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum. Int J Cancer. 1974; 13(4):478-88. DOI: 10.1002/ijc.2910130406. View

16.

Prehn R, MAIN J . Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst. 1957; 18(6):769-78. View

17.

Bomford R . Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells. Br J Cancer. 1975; 32(5):551-7. PMC: 2024810. DOI: 10.1038/bjc.1975.260. View

18.

FOLEY E . Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 1953; 13(12):835-7. View

19.

TUTTLE R, NORTH R . Mchanisms of antitumor action of Corynebacterium parvum: nonspecific tumor cell destruction at site of immunologically mediated sensitivity reaction to C. parvum. J Natl Cancer Inst. 1975; 55(6):1403-11. DOI: 10.1093/jnci/55.6.1403. View

20.

Scott M . Potentiation of the tumor-specific immune response by Corynebacterium parvum. J Natl Cancer Inst. 1975; 55(1):65-72. DOI: 10.1093/jnci/55.1.65. View